Erythropoietin (EPO) is a glycoprotein hormone that is primarily produced by the kidneys in response to hypoxia, although it can also be synthesized in the liver. It belongs to the class of pituitary and trophic hormones and plays a crucial role in the regulation of red blood cell production. Synthetic forms of erythropoietin, such as epoetin alfa, are used in clinical settings to treat anemia, particularly in chronic kidney disease and cancer patients undergoing chemotherapy. Researchers have extensively studied both endogenous and synthetic erythropoietin for their physiological and therapeutic roles. The primary physiological role of erythropoietin is to stimulate erythropoiesis, the process of red blood cell production in the bone marrow. It is crucial for maintaining adequate oxygen-carrying capacity in the blood. Research has also explored its potential neuroprotective and cardioprotective effects, although these areas require further investigation. Erythropoietin exerts its effects by binding to the erythropoietin receptor (EPOR) on erythroid progenitor cells in the bone marrow. This binding activates the JAK2/STAT5 signaling pathway, leading to the proliferation and differentiation of these progenitor cells into mature red blood cells. Researchers have observed that this mechanism is critical for the hormone's erythropoietic function. The pharmacokinetics of erythropoietin vary between its endogenous and synthetic forms. Endogenous erythropoietin has a circulating half-life of approximately 5-9 hours. Synthetic forms, such as epoetin alfa, have a longer half-life, particularly when administered subcutaneously. The metabolism primarily occurs in the liver, and the hormone is excreted by the kidneys. Clinically, erythropoietin is used to treat anemia associated with chronic kidney disease, chemotherapy, and certain other conditions. It is approved by regulatory agencies such as the FDA and EMA for these uses. However, its use is carefully regulated due to potential risks, including thromboembolic events. Researchers continue to explore its broader therapeutic potential while adhering to regulatory guidelines.